[
  {
    "ts": null,
    "headline": "Reasons to Retain TransMedics Stock in Your Portfolio for Now",
    "summary": "TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook.",
    "url": "https://finnhub.io/api/news?id=75e3c3e5cded51fb3df7c7a8764f0692ef8b4b51603980ed7c51df7bc948aff7",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765371900,
      "headline": "Reasons to Retain TransMedics Stock in Your Portfolio for Now",
      "id": 137750350,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "TMDX gains momentum as OCS technology, a robust pipeline and strong Q3 results fuel growth, though gross margin pressure tempers the outlook.",
      "url": "https://finnhub.io/api/news?id=75e3c3e5cded51fb3df7c7a8764f0692ef8b4b51603980ed7c51df7bc948aff7"
    }
  },
  {
    "ts": null,
    "headline": "CathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius速 System Version 3.5",
    "summary": "CathVision, a medical technology company dedicated to improving clinical outcomes in cardiac electrophysiology through high-fidelity signal acquisition and intelligent software, today announced two major milestones: the appointment of Eric Thepaut as independent Chairman of the Board, and the commercial release of Version 3.5 of the ECGenius速 System.",
    "url": "https://finnhub.io/api/news?id=4557af920448546359cfafad6fd7f2b3941991485eeccd6529b50e16a1af5423",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1765357200,
      "headline": "CathVision Announces Appointment of Eric Thepaut as Independent Chairman of the Board and Releases ECGenius速 System Version 3.5",
      "id": 137750351,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "BSX",
      "source": "Yahoo",
      "summary": "CathVision, a medical technology company dedicated to improving clinical outcomes in cardiac electrophysiology through high-fidelity signal acquisition and intelligent software, today announced two major milestones: the appointment of Eric Thepaut as independent Chairman of the Board, and the commercial release of Version 3.5 of the ECGenius速 System.",
      "url": "https://finnhub.io/api/news?id=4557af920448546359cfafad6fd7f2b3941991485eeccd6529b50e16a1af5423"
    }
  }
]